Acer Therapeutics, Inc.

Home » Acer Therapeutics, Inc.

Secondary

Acer Therapeutics, Inc.

They are a a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need.

Symbol

ACER

Last Closing Price
$14.15

Shares
760,000

Effective Date
December 12, 2017

Underwriters
William Blair

To view the prospectus for Acer Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253